Calumet Inc is a producer of specialty products, including base oils, specialty oils, solvents, esters, and waxes, as well as a variety of fuel and fuel-related products, including asphalt and heavy fuel oils... Show more
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| WEED | 19.35 | 0.52 | +2.79% |
| Roundhill Cannabis ETF (WEED) | |||
| CPAI | 53.23 | 0.15 | +0.28% |
| Counterpoint Quantitative Equity ETF (CPAI) | |||
| DDFO | 23.11 | 0.05 | +0.22% |
| Innovator Equity Dual Directional 15 Buffer ETF - October (DDFO) | |||
| DDFM | 20.23 | 0.03 | +0.16% |
| Innovator Equity Dual Directional 15 Buffer ETF - March (DDFM) | |||
| FTGC | 30.83 | -0.15 | -0.47% |
| First Trust Global Tactical Commodity Strategy Fund (FTGC) | |||
A.I.dvisor tells us that CLMT and FUL have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CLMT and FUL's prices will move in lockstep.
| Ticker / NAME | Correlation To CLMT | 1D Price Change % | ||
|---|---|---|---|---|
| CLMT | 100% | -6.17% | ||
| FUL - CLMT | 31% Poorly correlated | +0.18% | ||
| AXTA - CLMT | 30% Poorly correlated | +3.64% | ||
| RPM - CLMT | 29% Poorly correlated | -0.24% | ||
| SNES - CLMT | 25% Poorly correlated | +8.81% | ||
| SCL - CLMT | 25% Poorly correlated | +1.12% | ||
More | ||||
| Ticker / NAME | Correlation To CLMT | 1D Price Change % |
|---|---|---|
| CLMT | 100% | -6.17% |
| Process Industries category (164 stocks) | -3% Poorly correlated | +0.40% |
| Chemicals: Specialty category (61 stocks) | -4% Poorly correlated | -0.09% |
a producer of specialty hydrocarbon products
Industry ChemicalsSpecialty
CLMT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 35 of 39 cases where CLMT's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 90%.
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
Following a +3.85% 3-day Advance, the price is estimated to grow further. Considering data from situations where CLMT advanced for three days, in 263 of 326 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.
The Aroon Indicator entered an Uptrend today. In 159 of 212 cases where CLMT Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 75%.
The 10-day RSI Indicator for CLMT moved out of overbought territory on September 22, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 47 similar instances where the indicator moved out of overbought territory. In 33 of the 47 cases, the stock moved lower in the following days. This puts the odds of a move lower at 70%.
The Momentum Indicator moved below the 0 level on October 19, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CLMT as a result. In 60 of 75 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 80%.
The Moving Average Convergence Divergence Histogram (MACD) for CLMT turned negative on October 19, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 42 similar instances when the indicator turned negative. In 33 of the 42 cases the stock turned lower in the days that followed. This puts the odds of success at 79%.
CLMT moved below its 50-day moving average on October 21, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CLMT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 77%.
The Tickeron Profit vs. Risk Rating rating for this company is 8 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 82, placing this stock better than average.
The Tickeron Valuation Rating of 9 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-4.065) is normal, around the industry mean (2.360). P/E Ratio (-34.149) is within average values for comparable stocks, (-17.218). Projected Growth (PEG Ratio) (1.070) is also within normal values, averaging (1.548). Dividend Yield (0.052) settles around the average of (0.040) among similar stocks. P/S Ratio (1.100) is also within normal values, averaging (48.960).
The Tickeron Price Growth Rating for this company is 35 (best 1 - 100 worst), indicating steady price growth. CLMT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron PE Growth Rating for this company is 66 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.